Neuromuscular Stimulator Treats Gait Deficits in MS Patients
By HospiMedica International staff writers Posted on 07 Apr 2021 |
Image: Neuromuscular Stimulator Treats Gait Deficits in MS Patients (Photo courtesy of Helius Medical)
A novel neuromuscular tongue stimulator provides short-term treatment of gait deficit resulting from multiple sclerosis (MS).
The Portable Neuromodulation Stimulator (PoNS), a product of Helius Medical (HMT; Newtown, PA, USA), is a non-implantable device that delivers mild neuromuscular electrical stimulation to the dorsal surface of the tongue, a process called translingual neurostimulation (TLNS). TLNS stimulates both the trigeminal and facial nerves, creating a flow of neural impulses that are then delivered directly into the brain stem. From there, these impulses activate or reactivate neurons and structures involved in human function--the cortex, spinal cord, and potentially the entire central nervous system.
PoNS consists of a controller and a connected mouthpiece, held lightly in place by the lips and teeth. The controller, draped around the neck during therapy, sends signals to the tongue via the mouthpiece; in turn, receptors on the tongue send millions of neural impulses to the brain through natural pathways. PoNS is intended as a short term treatment (up to 14 weeks) of gait deficit due to mild and moderate MS symptoms, and mild-to-moderate traumatic brain injury (TBI), in conjunction with physical therapy. Therapists can connect view usage data and identify potential areas of missed or shortened sessions.
Multiple sclerosis is an inflammatory disease in which the fatty myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and scarring as well as a broad spectrum of signs and symptoms, such as problems with walking and balance, which interfere with daily activities, but or manageable. The most common walking problem is unsteady, uncoordinated movements (known as ataxia) due to damage to the areas of the brain that coordinate muscle balance.
Related Links:
Helius Medical
The Portable Neuromodulation Stimulator (PoNS), a product of Helius Medical (HMT; Newtown, PA, USA), is a non-implantable device that delivers mild neuromuscular electrical stimulation to the dorsal surface of the tongue, a process called translingual neurostimulation (TLNS). TLNS stimulates both the trigeminal and facial nerves, creating a flow of neural impulses that are then delivered directly into the brain stem. From there, these impulses activate or reactivate neurons and structures involved in human function--the cortex, spinal cord, and potentially the entire central nervous system.
PoNS consists of a controller and a connected mouthpiece, held lightly in place by the lips and teeth. The controller, draped around the neck during therapy, sends signals to the tongue via the mouthpiece; in turn, receptors on the tongue send millions of neural impulses to the brain through natural pathways. PoNS is intended as a short term treatment (up to 14 weeks) of gait deficit due to mild and moderate MS symptoms, and mild-to-moderate traumatic brain injury (TBI), in conjunction with physical therapy. Therapists can connect view usage data and identify potential areas of missed or shortened sessions.
Multiple sclerosis is an inflammatory disease in which the fatty myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and scarring as well as a broad spectrum of signs and symptoms, such as problems with walking and balance, which interfere with daily activities, but or manageable. The most common walking problem is unsteady, uncoordinated movements (known as ataxia) due to damage to the areas of the brain that coordinate muscle balance.
Related Links:
Helius Medical
Latest Patient Care News
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
- World's First AI-Ready Infrasound Stethoscope Listens to Bodily Sounds Not Audible to Human Ear